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Ambient air pollution and thrombosis
Sarah Robertson1* and Mark R. Miller2
Abstract
Air pollution is a growing public health concern of global significance. Acute and chronic exposure is known to
impair cardiovascular function, exacerbate disease and increase cardiovascular mortality. Several plausible biological
mechanisms have been proposed for these associations, however, at present, the pathways are incomplete. A
seminal review by the American Heart Association (2010) concluded that the thrombotic effects of particulate air
pollution likely contributed to their effects on cardiovascular mortality and morbidity. The aim of the current review
is to appraise the newly accumulated scientific evidence (2009–2016) on contribution of haemostasis and
thrombosis towards cardiovascular disease induced by exposure to both particulate and gaseous pollutants.
Seventy four publications were reviewed in-depth. The weight of evidence suggests that acute exposure to fine
particulate matter (PM2.5) induces a shift in the haemostatic balance towards a pro-thrombotic/pro-coagulative
state. Insufficient data was available to ascertain if a similar relationship exists for gaseous pollutants, and very few
studies have addressed long-term exposure to ambient air pollution. Platelet activation, oxidative stress, interplay
between interleukin-6 and tissue factor, all appear to be potentially important mechanisms in pollution-mediated
thrombosis, together with an emerging role for circulating microvesicles and epigenetic changes.
Overall, the recent literature supports, and arguably strengthens, the contention that air pollution contributes to
cardiovascular morbidity by promoting haemostasis. The volume and diversity of the evidence highlights the
complexity of the pathophysiologic mechanisms by which air pollution promotes thrombosis; multiple pathways
are plausible and it is most likely they act in concert. Future research should address the role gaseous pollutants
play in the cardiovascular effects of air pollution mixture and direct comparison of potentially susceptible groups to
healthy individuals.
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Background
Outdoor air pollution is estimated to be responsible for
over 3 million premature deaths worldwide [1], and thus
represents one of the leading risk factors for all cause
disease [2, 3]. Of these, the vast majority of deaths are
attributed to cardiovascular disease (CVD) [1]. Throm-
bosis is the most common underlying pathology trigger-
ing the two major cardiovascular disorders: coronary
heart disease and stroke. While many of the biological
mechanisms underlying the link between air pollution
and CVD remains uncertain, the seminal American
Heart Association (AHA) review concluded that throm-
botic mechanisms may in part explain the observation
that exposure to air pollution is associated with adverse
cardiovascular events [4]. The aim of the current review
is to examine the newly accumulated scientific evidence
(2009–2916) on whether or not mechanisms of haemosta-
sis and thrombosis contributes towards CVD induced by
exposure to air pollution. The remit of this review also ex-
tends to gaseous pollutants, which had not been previ-
ously reviewed by the AHA statement [4]. This work
forms part of a larger ongoing piece of work being under-
taken by the Committee on the Medical Effects of Air Pol-
lutants on estimating the effect of long-term exposure to
ambient air pollution on cardiovascular morbidity in the
UK today
Air pollution is a complex heterogeneous mixture of
gases and particles, arising from a wide variety of station-
ary and mobile sources; both directly emitted (primary
emissions) or formed within the atmosphere (secondary
emissions). From a health perspective, nitrogen oxides
(NOx) and particulate matter (PM) currently receive the
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greatest attention, although ozone (O3) and sulphur diox-
ide (SO2) also have potential to cause harm. PM is itself a
complex mixture of airborne particles that differ in size,
origin and chemical composition. Particles are classified
into three classifications based on aerodynamic diameter;
coarse (PM10, 2.5–10 μm) fine (PM2.5, <2.5 μm) and ultra-
fine (UFP, <100 nm). At present only PM10 and PM2.5 are
widely monitored (and regulated) in the environment,
with most attention given to PM2.5 due to the greater
penetration into the lung alveoli and its high reactive sur-
face area for a given mass. On this basis and others (e.g.
translocation into the blood, different surface compos-
ition), UFPs could represent a greater threat to health, but
at present cannot be measured routinely in large numbers
of individuals without using surrogates such as particle
number count (PNC).
There is persuasive evidence, particularly for PM, on the
negative impact of air pollution on cardiovascular events
and outcomes, including electrocardiographic changes
(e.g. reduced heart rate variability), endothelial dysfunc-
tion, atherosclerosis and thrombosis. The biological mech-
anisms underpinning the effects of air pollution on CVD,
however, remain poorly defined. Nonetheless, three main
hypothesis have been proposed by which air pollution that
is inhaled into the pulmonary system can then instigate
remote cardiovascular effects: 1) particle induced inflam-
matory responses in the lungs, leading to the release of in-
flammatory and oxidative mediators into the circulation;
2) pollutant-induced activation of airway sensory nerves
resulting in autonomic imbalance; and 3) direct entry of
pollutants (usually with a focus on particles or chemical
constituents) into the pulmonary circulation before being
carried into the systemic circulation (Fig. 1).
Haemostasis is a complex, orchestrated series of event
events to maintain circulating blood in the liquid state
and to prevent blood loss following injury through the
formation of a blood clot. Excessive clotting, especially
in patients with pre-existing CVD, can block major ar-
teries leading to a loss of downstream blood flow, and
potentially leading to clinical events such as heart attack,
ischaemic stroke or death. In contrast, a reduction in the
ability of blood to clot can lead to uncontrolled bleeding
with severe blood loss from injury or escape of blood
following aneurysm, e.g. thrombotic stroke. Thus the
body maintains an intricate balance to preserve haemo-
stasis; a process that involves the interplay of circulating
blood cells, a variety of coagulation factors, platelets and
fibrinolytic factors, as well as interactions with the vas-
cular wall and endothelial cell-derived mediators (Fig. 2).
Clotting may be initiated by either the intrinsic (contact
activation) or extrinsic pathway (tissue factor; TF). These
two pathways converge into a final common pathway of
thrombin production and fibrin clot formation (Fig. 3).
In this review, we use the term “haemostasis” to include
the whole process: platelet activation, coagulation and fi-
brinolysis. Exposure to air pollution has been shown to in-
fluence each of these dynamic processes, with increasing
evidence suggesting that the overall haemostatic balance
is shifted towards a pro-coagulant and anti-fibrinolytic
state [4]. The 2010 AHA report [4] concluded that there
was evidence, albeit somewhat inconsistent, suggesting
that PM may adversely affect haemostasis shifting the bal-
ance to a pro-coagulant and anti-fibrinolytic state and that
this may, in part, contribute to the effects of air pollution
on CVD. The mechanisms underlying such an effect were
poorly defined but systemic inflammatory activation and
alterations in platelet function are proposed as key pro-
cesses involved in the alterations in haemostasis [4].
This review provides an overview of the updated lit-
erature in the area of air pollution, which has growing
increasingly topical, with a specific focus on the throm-
botic actions given the contribution that pathway could
make to the substantial cardiovascular morbidity of air
pollution. In our overview we highlight recent advances
and explore mechanistic understanding of the pathways
linking air pollution exposure and haemostasis parame-
ters. Improved understanding is needed to provide crucial
insight into which pollutants are most harmful, who may
be most at risk, and informs future research needs and
public health policy in respect of advice and interventions.
Search strategy and review structure
Search strategy
This work uses the 2010 AHA scientific statement [4],
as an expert review of the literature between January
2004 to March 2009, as a foundation for reviewing the
research in this area in the subsequent years. Literature
searches were performed in PubMed from the dates of
1st January 2009 to 28th February 2016, using the follow-
ing search terms: “air pollution” or “particulate matter”
and “blood” or “thrombosis” or “clot” or “fibrinolysis” or
“coagulation” or “embolism” or “platelet”. Terms for gas-
eous were not included due to the large number of irrele-
vant references these terms produced. Preliminary checks
were performed to ensure that relevant references with
gaseous pollutants were captured by the term “air pollu-
tion”. Other papers were identified from prior knowledge,
contact with experts in the field and hand searching of the
bibliographies of the papers identified in the electronic
search. References were downloaded into the referencing
software program Endnote (version X8).
Study selection
A total of 2326 publications were identified following re-
moval of duplicates (Fig. 4). These were screened first at
the abstract level, and then at the full article level. To be
included in the final analysis studies had to meet the
following inclusion criteria:
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 Peer-reviewed articles or published by a recognised
institution between 1st January 2009 and 28th
February 2016*
 Study type: epidemiological studies, human
controlled exposures and intervention studies, in
vivo (animal) studies
 Exposure: ambient (outdoor) air pollution –
particulate air pollutants**, diesel exhaust (DE),
O3, nitrogen dioxide (NO2), carbon monoxide
(CO), SO2
 Health outcome: reported on coagulation, fibrinolysis,
thrombophilia and platelet profile
 Population: general population (all ages, those with
pre-existing health conditions)
* Key earlier publications are discussed for contextual
background.
** Included PM size fractions, black carbon (BC),
concentrated ambient particles (CAPs) and PM from DE
(i.e. diesel exhaust particles (DEP)).
Key exclusion criteria included:
 No original data included (e.g. reviews, editorials
and commentaries were excluded). However,
reference lists from the identified original articles
and reviews were screened to identify any other
potentially relevant studies.
 Language: full text not available in the English Language
 Study type: in vitro
 Exposure not relevant to ambient air pollution
(e.g. indoor air pollution, occupational exposure***,
biomass, cigarette smoke, manufactured nanoparticles)
 Did not provide any mechanistic data beyond
mortality or hospital admission
Fig. 1 Flowchart showing the three main hypotheses of how inhaled particles could cause cardiovascular impairment. Adapted from Niemann
et al. [78]
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*** Occupational exposure to manufactured nanoparti-
cles, industrial accidents and environmental events (e.g. vol-
canic eruptions or wildfires) were not included. Workplace
exposures that potentially spill into communities or were
representatives of the main aspects of general urban
air pollution (e.g. engine emissions from garages, bus
depts.) were included.
Review structure
This review provides a narrative summary of the seventy
four publications that fulfilled all inclusion criteria. The
piece has been structured by study type: epidemiological
studies (62%) controlled exposure studies in man (15%)
and in vivo animal studies (23%). Epidemiological studies
were further subdivided into short-term (7 days of ex-
posure or less) versus long-term (>1 week of exposure).
Emphasis has been given as to whether the conclusions
of the AHA statement have been strengthened during
the 8-year period and where new insight has been made
as to possible underlying mechanisms. Of note, we ex-
pand the remit from the AHA statement by inclusion of
gaseous pollutants (e.g. NO2, O3, CO and SO2).
Epidemiological studies
Short-term exposure to air pollutants
The vast majority of epidemiological studies addressing
the haemostatic effects of air pollution have investigated
acute exposures (<7 days), with most evaluating alter-
ations in plasma biomarkers of systemic coagulation and
fibrinolysis. Fibrinogen, an essential coagulation protein
associated with an increased risk of coronary events
[5, 6], has been one of the most studied. Hildebrandt
and colleagues reported PM to be associated with a
2.4% increase in fibrinogen from 3.1 g/L (baseline) in 38
male patients with chronic obstructive pulmonary disease
(COPD) [7]. However, no clear pattern emerged for the
other plasma haemostatic biomarkers evaluated. Thus, the
increase in fibrinogen in response to exposure may be
somewhat artificial, perhaps arising from small sample
bias. With a larger sample size (N = 242), another study
noted no increase plasma fibrinogen levels in patients with
COPD per interquartile range (IQR) increase in PM2.5 at
all lag days (0–10) [8]. Similarly, there were no significant
changes in fibrinogen with PM exposure among young
and older adults [9–11]. Besides fibrinogen, other bio-
markers having pro-coagulant properties or reflecting a
pro-thrombotic state have been investigated (including,
(plasminogen activator inhibitor type 1 (PAI-1) and tissue-
type plasminogen activator (t-PA)) [10, 12, 13]. Earlier
studies typically analysed single biomarkers of haemosta-
sis, whereas more recent studies have used a multiple bio-
marker approach. While most studies have observed
pollution-related changes in at least one biomarker, the
direction and statistical significance of the pollutant-
biomarker association has not been consistent, making it
difficult to generalise conclusions. More convincing evi-
dence for associations between exposure to ambient parti-
cles and biomarkers of haemostasis comes from studies
Fig. 2 Processes and components involved in normal haemostasis (these are discussed in more detail in the text)
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conducted during the 2008 Beijing Olympics [10, 14]. The
air pollution control measures that were put in place in
Beijing during the 2008 Olympic Games provided an un-
precedented opportunity for quasi-experimental studies to
assess the effect on systemic biomarkers of haemostasis
and inflammation, among others. The short-term reduc-
tions in PM during the Olympic Games was associated
with decreases in biomarkers of haemostasis [10, 14].
During the 2008 Beijing Olympic Games, Rich et al.
(2012) observed statistically significant improvements in
soluble P-selectin (sP-selectin; −34%) and von Willebrand
(vWF; −13.1%) among, the 125 healthy young adults
studied [14]. An interesting study by Delfino et al. (2009)
examined whether medication use modifies the associ-
ation between particulate air pollution and biomarkers of
haemostasis. Here, an association between PM2.5 exposure
and blood levels of sP-selectin in coronary artery disease
(CAD) was only observed in those not taking clopidogrel,
providing further evidence for a role of platelets [12].
Further studies are warranted to disentangle the modify-
ing effects of health status and use of different medica-
tions, in addition to whether such preventative action of
anti-platelet agents are more marked in those with great-
est exposure to air pollutants.
Inconsistencies between studies are also likely to reflect
the differences in the accuracy of the exposure assessment
for individual volunteers. Studies have generally relied on
data collected from the nearest fixed-ambient monitoring
stations as a surrogate for personal exposure. Unless
complex modelling has been performed a key weak-
ness in using fixed-site monitoring data is that it ignores
spatial variability. Differences in particle composition
across study locations could also be a reason for the in-
consistent findings, as physical and chemical characteris-
tics of PM are known to vary widely both with space and
time [15, 16]. Very few studies have analysed associations
between individual PM constituents and changes in bio-
markers of haemostasis. There is limited/suggestive epi-
demiological evidence that the haemostatic responses are
more intrinsically related to chemical composition rather
than just particle mass. For example, Wu et al. (2012)
demonstrated that certain transition metals (e.g. iron, ti-
tanium, cobalt and cadmium) within PM2.5, but not PM
mass, was associated with increased plasma fibrinogen
levels among healthy adults in Beijing. Besides fibrinogen,
biomarkers of the fibrinolytic pathway (PAI-1 and t-PA)
were also significantly and positively associated with tran-
sition metals in PM2.5. These epidemiological observations
Fig. 3 The intrinsic, extrinsic and common pathways of the coagulation (clotting) cascade. Air pollution has been shown to affect several steps in
blood coagulation (these are discussed in more detail in the text)
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are consistent with animal and in vitro studies showing a
role for transition metals in the PM-induced toxicity [17].
Additionally, studies have shown the administration of
chelating agents (chemical compounds that react with
metal ions, to decrease their availability for other reac-
tions) can block the effects of air pollution on blood co-
agulation [18]. Several transition metals have been shown
to participate in Fenton and Fenton-like reactions and
thus induce oxidative stress. Oxidative stress is a reoccur-
ring mechanism in actions of air pollution [19], and asso-
ciations between exposure and biomarkers of oxidative
stress have been observed in both in vivo and in vitro
studies [20]. To the best of our knowledge, only one study
that has investigated the effects of genetic polymorphisms
related to oxidative stress and particulate pollution
exposure on markers of haemostasis [21]. Stronger as-
sociations between PM and haemostatic biomarkers
were observed among individuals who were genetically
predisposed to oxidative damage [21]. However, unexpect-
edly, exposure was associated with a decrease in the levels
of circulating biomarkers of haemostasis, counter
intuitively suggesting a potentially protective effect of PM
against thrombosis [21]. Besides oxidative-stress related
polymorphisms, other epidemiological studies have inves-
tigated the effect of polymorphisms in the fibrinogen
genes on responses to PM exposure [22]. For example,
carriers of the FGB rs1800790 minor allele elicited greater
fibrinogen responses to PM than those with a major allele
[22]. Such ‘unforeseen’ functional consequences of genetic
polymorphisms may, in part, account for discrepant find-
ings between studies investigating different populations.
Further work in this area is clearly warranted.
Size distribution in ambient air may also be important.
An increasing body of experimental data (see below) has
shown that the ultrafine fraction within PM is more
toxic than the fine or coarse fractions, attributed to the
larger surface area per unit mass of ultrafine particles
(UFPs). The large majority of these studies have focussed
on pulmonary responses and as yet, there are too few
population studies to conclude whether different particle
size fractions have different magnitudes of association
with haemostatic outcomes. Only a few studies have spe-
cifically investigated the effect of particle size on the
haemostatic effects of PM and results have been mixed
[10, 12, 21, 23, 24]. This is likely the consequence of lim-
ited statistical power of studies together with methodo-
logical heterogeneity. Of particular interest is the study
by Rückerl et al. (2014) which used a particle counter
with a lower particle cut-off size than the more conven-
tional methods. Nevertheless, analysis of the different
size fractions of UFP (3–10 nm, 10–30 nm, 30–50 nm,
50-100 nm) did not reveal a certain size range to be
more influential than others. Also, associations were
stronger for PM2.5 than for UFPs; inconsistent with the
notion that UFPs have greater biological activity, al-
though it is noteworthy that this study found a reduced
thrombus formation in association with PM.
There is some limited evidence that different particle
sizes have different intervals of time (lag) between ex-
posure and biomarker changes, suggesting that the mode
of action may be different for the various particle sizes
[10]. It has been suggested that inhaled UFPs may trans-
locate into the circulation [25–27] with the potential for
direct pro-aggregatory effects on platelets. However, par-
ticle translocation remains controversial and a recent
study showed that the translocated fraction is less than
1% (mass) of the delivered dose to the lung [28]. The
exact pathway for the translocation into the circulation
also remains unclear. While some studies [10], report as-
sociations between haemostatic biomarkers and concen-
trations of ambient UFPs for time lags representing direct
effects (ie. lag 0), the time course of others [29] is more
likely to represent indirect effects, with findings very rarely
being consistent across studies for the same biomarker-
pollutant pair. It is also not clear whether inflammatory
Fig. 4 Flowchart showing the numbers of papers included/excluded
at each stage of the search strategy
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processes mediate the exposure-response relationship. It
has been shown that exposure to particulate air pollution
can induce platelet aggregation and increased thrombin
generation without inducing significant levels of inflam-
mation [29]. Others have suggested that an inflammatory
response is an essential component in the haematological
changes associated with short-term exposure to air pollu-
tion [10, 13, 30]. Of note, most studies have looked at a
limited number of inflammatory biomarkers and these
may not necessary encompass all aspects of the inflamma-
tion response.
There has been limited progress in the use of global
coagulation tests in epidemiological studies of short-term
exposure. Measurement of individual biomarkers provides
only ‘snapshots’ of the overall coagulation process, and
global coagulation tests can provide a more complete pic-
ture of haemostatic status. The prothrombin time (PT)
test (measures activity of the extrinsic and common path-
ways) and the activated partial thromboplastin time
(APTT) test (measures activity of the intrinsic and com-
mon pathways) are widely used global screening tests for
blood coagulability. To date, efforts have primarily focused
on PM. Shortened PT (i.e. greater coagulability of the
blood) has been demonstrated in 1218 normal subjects
from the Lombardia Region, Italy after short-term expos-
ure to PM10 [31]. No changes in APTT were noted, per-
haps instead pointing towards TF-dependent changes in
thrombin generation. This result is contrary to a more re-
cent study showing prolonged clotting times with in-
creased levels of PM10 in a group of 233 patients with
diabetes [13]. However, reduced clotting times were asso-
ciated with increasing PM10 concentrations of the sub-
acute exposure windows (day 0 to day 3) [13].
One of the most exciting areas to have developed in
recent years, has been increasing interest in uncovering
whether environmental exposures can impact on health
through epigenetic mechanisms (alterations in gene ex-
pression and function without changing the underlying
DNA sequence), such as DNA methylation, histone modi-
fications and non-coding RNA expression [32]. Alter-
ations of DNA methylation have been linked to various
human diseases, and epidemiological studies have shown
distinct DNA methylation abnormalities with exposure
to air pollutants [33, 34]. Evidence for associations
between (i) air pollution and epigenetic alterations
and (ii) between disease states (including CVD) and
epigenetic changes, lends biological plausibility for
epigenetic change underpinning the effects of air pollution
on haemostasis. The most compelling evidence comes
from a recent study demonstrating that exposure to black
carbon (BC) particles was associated with a decrease in
DNA methylation (hypomethylation) of the tissue factor
(F3) gene and subsequent increases in fibrinogen protein
expression [35]. The specific mechanism of how air
pollution exposure may alter DNA methylation has not
been elucidated at present.
Unlike PM, there have been relatively few studies evalu-
ating the relationship between gaseous pollutants and bio-
markers of haemostasis, and the evidence has been mixed.
The evidence has been mixed with some showing positive
associations, some showing no association and a few
showing inverse associations [7, 8, 11, 12, 14, 24, 29]. The
heterogeneity of these studies makes the data difficult to
interpret as studies have tended to use different exposures
(NO2, CO), target populations or outcome measures.
Long-term exposure to air pollutants
As with the studies of short-term exposure to PM dis-
cussed above, fibrinogen has been the most widely studied
biomarker in long-term exposure (>1 week) epidemio-
logical studies. Using data from the Heinz Nixdorf Recall
Study (a prospective population-based cohort of 4814
German adults) plasma fibrinogen levels were found to be
elevated by 3.9% among men, but not women, for each
3.91 μg/m3 increase in annual average PM2.5 [36]. This
was found to be independent of short-term changes in air
pollution. However, a comparative study using a higher
spatial resolution (1 km as compared to 5 km) did not
confirm this finding [37]. Large population-based cohort
studies in the US and UK have also reported no associ-
ation between fibrinogen and PM [30, 38–40]. Studies also
varied in their ability to adjust for potential confounding
factors (medication use, co-morbidities, socio-economic
status (SES)). Additionally, different exposure patterns and
sources are likely to contribute to the inconsistent results
among studies. Evidence from a multi-center and meta-
analysis found that long-term exposure to zinc within
PM2.5, but not other constituents (e.g. iron and nickel) in-
creased fibrinogen concentrations [41]. These findings
add to the growing evidence that mass alone does not fully
capture the toxicity potential of PM.
A few studies have looked at other markers of clotting
and fibrinolysis, with considerable differences in the magni-
tude and direction of responses obtained [30, 37, 42, 43].
Factor VII (FVII) plays a central role in initiating the
process of coagulation. A cohort study of 2086 mid-life
women found an inverse relationship with FVII (−3.6%;
95% Cl, −7.8 to 0.8%) for each additional 10 μg/m3 of an-
nual PM2.5 pollution [42], pointing towards a more hypo-
coagulable state. However, the measurement and analysis of
one or more coagulation biomarkers may not provide a
complete picture of the balance between thrombosis
and lysis. For example, long-term exposure to PM led
to enhanced thrombin generation in patients with dia-
betes, in the absence of pro-coagulant changes in co-
agulation parameters (FVII, FVIII, FXII) [13]. The
evidence has, for the most part, been directed at par-
ticulate air pollutants. Differences in the focus and
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design of investigations addressing gaseous air pollut-
ants make it difficult to draw meaningful conclusions
as to the long-term relationship with coagulation
markers [8, 30, 40, 42, 44, 45].
A small number of studies have made use of global co-
agulation tests in long-term epidemiological studies. Re-
duced clotting times were observed in association with
PM10 average over one year among healthy controls and
patients with deep vein thrombosis [46]. Patients with
diabetes showed hypercoagulability, using endogenous
thrombin potential (ETP) with PM10 for time windows
up to 6 months in patients with diabetes [13]. Interest-
ingly, associations between PM10 exposure up to one
month, but not longer, and thrombin generation were
dependent on TF. The authors proposed microvesicles
(small membrane-bound structures secreted from differ-
ent cell types) to be the main source of the TF [13]. In-
creased levels of TF-positive microvesicles were also
detected in the plasma of diabetic patients for mean
PM10 measurement over 1 year [13].
Induction of systemic inflammation by air pollution
could contribute to a pro-thrombotic state. Consistent
with this notion, Viehmann et al. (2015), using data from
the Heinz Nixdorf Recall Study, observed a positive cor-
relation between C-reactive protein (CRP; a marker of
systemic inflammation) and platelet count in relation to
air pollution [37]. However, other studies have found no
clear patterns of association between markers of haemo-
stasis and markers of inflammation [13, 40, 44]. In the
study by Emmerechts et al. (2012), a systemic inflamma-
tory state could not explain the pro-coagulant during
the longer time windows (1 month to 1 year) [13]. Only
a limited number of studies have examined whether age,
gender, and pre-existing co-morbidities influence the
haemostatic effects of long-term air pollution exposure
and results have been inconsistent. For example, Forbes
et al. (2009) found no effect modification by gender for
associations for PM and fibrinogen, whereas PM expos-
ure was associated with increasing fibrinogen levels in
men, but not women, in the population-based Heinz
Nixdorf Recall cohort study [36]. The latter study is of
particular interest as it controlled for a large number of
confounding variables. Nevertheless, the study produced
some unexpected results, showing no effect modification
by medication use or co-morbidities on the association
between PM and fibrinogen.
In summary, much of the recent epidemiological research
has strengthened the evidence of associations between
short- and long-term particulate air pollution exposure
and changes in haemostasis. Increased use of assays of glo-
bal coagulation, reflecting events from beginning of clot for-
mation to fibrinolysis, has contributed to strengthening the
evidence that particulate pollutants could cause throm-
botic events. However, changes have been modest and, at
times, inconsistent. Furthermore, it is not clear whether
differences in susceptibility exist within populations (for ex-
ample, age, sex, pre-existing disease). The magnitude of
these changes is in general small, and their clinical rele-
vance has yet to be ascertained. It is, however, possible
that, if untreated, these haemostatic changes over the long-
term could ultimately lead to exacerbation of myocardial
ischaemia and other clinical outcomes in response to a
triggering factor. The current evidence is too sparse to draw
conclusions about the effects of exposure of gaseous pollut-
ants on haemostasis.
Controlled human exposure studies
Controlled human exposure studies provide a means to
investigate biological mechanisms for pollutants in isola-
tion with fewer confounding variables. Despite the hetero-
geneity in study design and the possibility of publication
bias against negative findings, it is difficult to deny that
particulate air pollution promotes a pro-thrombotic state.
In recent years, much of the research has focussed on DE
and CAPs. A series of controlled human exposure studies
have demonstrated impaired fibrinolysis, by measure-
ment of t-PA (the activator of fibrinolysis) in healthy
volunteers after exposure to DE generated under either
transient engine speed and load (300 μg/m3; 1 h) [47] and
idling (250 μg/m3; 1 h) conditions [48]. Similar observa-
tions have been observed in patients with coronary
heart disease (CHD) following DE exposure [49] and in
healthy volunteers after exposure to coarse CAPs
(89.0 μg/m3; 2 h) [50].
In recent years, major advances have been made in
supporting thrombus formation following DE exposure.
Ex vivo thrombus formation has been assessed, using
a Badimon chamber (mimics flow conditions within
the coronary circulation of man), after DE exposures
(320–350 μg/m3) lasting 1 and 2 h in healthy volunteers
[51, 52]. Interestingly, DE exposure was associated with
increased expression of platelet-leukocyte aggregates, as
well as increased circulating levels of soluble forms of
CD40L, suggesting that the enhanced thrombus formation
was mediated through platelet activation [51, 52]. DE ex-
posures did not have any significant effect on cellular and
soluble markers of inflammation [51, 52]. The latter sug-
gest that short-term exposure to DE may lead to a pro-
thrombotic state, independent of systematic inflammation.
However, these studies have been typically limited to
measuring a small number of blood markers of inflamma-
tion, and cannot exclude other markers of inflammation.
The question as to whether particulate air pollutants affect
platelets through direct and/or indirect effects thus re-
mains undetermined.
Significant advancements have been made in recent years
as to whether the anti-fibrinolytic, and pro-thrombotic re-
sponses are due to diesel PM or the associated DE gaseous
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components (or both). Acute exposures of healthy volun-
teers to DE with a particle trap abolished the effects on en-
dogenous fibrinolysis and ex vivo thrombus formation [51].
While the filters were effective in terms of particle removal
(reduced particle concentration by 98%), the catalytic oxide
coatings led to measurable increases in concentrations of
NO2. Nevertheless, a study by the same investigators found
that bradykinin-induced release of tPA into plasma did not
change significantly after exposure to NO2 at 4 ppm for
1 h [53], suggesting that NO2 does not appear to be a
major factor in the anti-fibrinolytic effects of dilute DE in-
halation. Strengthening the role of particles, thrombotic
effects appear to be relatively consistent in inhalation
studies performed using diesel engine emissions at
equivalent particle mass concentrations but different
gaseous components [52]. However, controlled exposure
to O3 (0.3 ppm for 2 h) reduced plasma PAI-1 within 24 h
in healthy volunteers, suggesting a pro-thrombotic effect
of O3 [54].
The source and chemical nature of the particles ap-
pears to be important. For example, exposure to CAPs,
from non-exhaust traffic related sources, did not signifi-
cantly affect the fibrinolytic balance in patients with
CHD [55]. Furthermore, a pure carbon nanoparticulate
exposure alone had no discernible effect on blood co-
agulation and fibrinolysis in healthy volunteers [56].
However, to date these effects have not been studied ex-
tensively and therefore only limited information is avail-
able on these issues. Although diesel motor emissions
constitute a significant proportion of UFPs in the urban
environment, it is as yet unclear which fraction of par-
ticulate from DE plays the largest role in the thrombo-
lytic/fibrinolytic effects. Studies using inhaled laboratory
generated ultrafine carbon particles (50 μg/m3; count
medium diameter, 32 nm; 2 h) – as surrogates for ambient
UFP- have reported platelet activation and increased vWF
(mediates platelet-platelet or platelet-vessel interaction)
levels in persons with type 2 diabetes [10, 57, 58].
Gene expression profiling analysis using microarray
has demonstrated changes in expression levels of genes
involved in the clotting cascade [59]. Expression of the
F2R gene (located at chromosome 5q13.3), which en-
codes the thrombin receptor, were elevated 30-fold in 14
healthy participants after a 1 h exposure to diluted DE
(300 μg/m3) compared to clean air [59]. In addition, DE
exposure decreased expression of the gene encoding the
urokinase-type plasminogen activator (PLAU), a secreted
serine protease involved in the breakdown of clots [59].
Genes related to oxidative stress pathways have been
shown to be differentially regulated in response to ex-
posure to air pollution. In particular, inducible nitric
oxide synthase 2A (NOS2A), a biomarker of oxidative
stress, was upregulated in healthy volunteers 24 h after
DE exposure (300 μg/m3, 60 min on 2 separate days)
[59]. Further evidence is required to confirm a role for
oxidative stress in causing PM-induced pro-coagulant/
thrombotic effects. It is also worth noting that the
changes in the gene expression level of coagulation
markers have not been frequently reflected at the protein
level after DE exposure.
Taken as a whole, controlled exposure studies in man
support the notion that particulate air pollution exposure
favours a pro-thrombotic state. The most common human
controlled inhalation studies are to DE. Exposures are
acute (1–2 h) and concentrations used are high, but within
the range that could occur in the urban environment (for
example, during high air pollution episodes or in areas of
dense traffic). It has been reported that O3exposure, but not
NO2, promotes thrombosis, but these are isolated studies. A
number of different mechanisms have been postulated to
mediate thrombogenic actions of particulate air pollution.
Arguably, one of the strongest hypotheses for the enhanced
thrombotic profile in response to exposure suggests an in-
crease in platelet activation. Inflammation and oxidative
stress continue to be implicated as a mechanism underlying
pollution-induced pro-thrombotic and anti-fibrinolytic ef-
fects, although findings are inconsistent. Most investigations
used young, healthy subjects and there is insufficient data
to ascertain whether pre-existing conditions further promote
the thrombogenic effects of air pollution.
In vivo studies in animals
Animal models provide greater flexibility to explore the
biological mechanisms of air pollutant exposure. In rela-
tion to the haemostatic system in particular, in vivo
models in which induction of thrombosis can be directly
studied, as opposed to relying on surrogates or biomarkers
alone, or blood clotting ex vivo in the absence of the vessel
wall, can be studied. Together with biomarkers, a detailed
assessment of effect and mechanism is possible. In recent
years, a variety of biological pathways have been argued
persuasively. In terms of environmental sources of air pol-
lution, the focus has remained on PM, through inhalation
of urban ambient particles or instillation techniques to de-
liver particulates in the absence of gases. There is increas-
ing evidence that the association between exposure to PM
and alterations in haemostasis is mediated, at least in part,
by interleukin-6 (IL-6). Mutlu et al. (2007) first drew our
attention to a role of IL-6 in mediating PM-related pro-
thrombotic effects [60]. In C57 mice, intratracheal ad-
ministration of coarse ambient particles (PM10; 10 μg),
collected from an urban background site in Düsseldorf,
Germany, increased lung production of IL-6, reduced clot-
ting times and enhanced thrombin generated within 24 h
compared with saline instillation [60]. Additionally, the
role of alveolar macrophages as the critical source of this
elevated IL-6 was confirmed by depleting alveolar macro-
phages using intracheally instilled liposomal clodronate
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[60]. IL-6 dependent activation of coagulation has also
been suggested in studies using different particle size frac-
tions and other exposure methods [61]. Work by Budinger
et al. (2011) demonstrated an IL-6-dependent increase in
coagulation activation markers (thrombin-anti-thrombin
(TAT)) following inhalation exposure (8 h per day, for
3 days) to fine CAPs (PM2.5; 88.5 ± 13.4 μg/m
3) and after
the instillation PM2.5 (200 μg) [61]. Unfortunately, be-
cause studies have used different methods in assessing
the haemostatic effects, makes comparisons between
studies difficult.
Budinger et al. (2011) also showed a role of IL-6 in the
increased levels of TF antigen following PM exposure
[61]. IL-6 knockout mice did not display the increased
levels of TF following inhalation exposure (8 h per day,
for 3 days) to fine CAPs (PM2.5; 88.5 ± 13.4 μg/m
3) and
after the instillation PM2.5 (200 μg) [61]. However, mea-
surements of TF antigen do not necessarily reflect the
functional capacity and integrity of TF [62]. Perhaps the
most convincing evidence for a role of TF in mediating
thrombus formation following exposure to PM comes
from the study by Kilinç et al. (2011) [62]. In mice intra-
tracheal administration of UFPs (approx. 0.36 μg) col-
lected near a Dutch roadside tunnel (mainly used by
heavy diesel trucks) increased plasma thrombin gener-
ation at 4 and 24 h post-exposure [62]. The extrinsic
pathway is initiated when TF comes in contact with and
activates factor VII (Fig. 3). Kilinç et al. (2011) showed
that the increased thrombin generation 4 h after expos-
ure to UFP to be blocked by administration of TF/FVIIa
inhibitor [62]. TF-driven thrombin generation was sup-
ported by observations that thrombin generation param-
eters were similar in wildtype and FXII (important
protein involved in the initiation of the intrinsic path-
way; Fig. 3) deficient mice 4 h after UFP exposure [62].
Of note, this study did not provide evidence for a causal
link between IL-6 and TF. The use of FXII knockout
mice to study the role of the intrinsic coagulation path-
way provided support for the intrinsic pathway in the
later phases of thrombin generation (20 h after UFP ex-
posure) [62]. While intratracheal instillation of UFP in-
creased thrombin generation in wildtype mouse plasma
at 20 h post-exposure, no effect was seen in FXII knock-
out mice. Similar results were obtained by pharmaco-
logical inhibition of FXII by the inhibitor corn trypsin
inhibitor [62]. Overall, these results suggest distinct
mechanisms regulate pollution-related haemostatic ef-
fects over different timescales. However, more studies
are needed with air pollution from different sources and
different particle sizes. Inhalation studies are also re-
quired. Intratracheal administration is a more artificial
route of delivering pollutants to the lungs and does not
simulate normal animal inhalation exposure conditions
[63]. Nevertheless, intratracheal instillation of particle
suspensions has been shown to be a reliable way of pro-
ducing excellent dispersion of particles throughout the
lobes of rodent lungs and across the surface of the al-
veoli, leading to pulmonary effects that are directly com-
parable to that of inhalation studies [64, 65].
The study by Kilinç et al. (2011) did not assess whether
the initiation of the intrinsic coagulation pathway following
exposure was a consequence of an inflammatory response
and/or particle translocation processes [62]. Interestingly,
Budinger et al. (2011) suggested that IL-6 is significantly as-
sociated with PM-induced thrombogenic effects independ-
ent of other inflammatory markers [61]. Two studies have
been published examining the effect of anti-inflammatory
agents on thrombogenic factors in mice following exposure
to DEP (15–30 μg) [66, 67]. Both studies demonstrated a
critical role for inflammation in mediating DEP-induced
thrombotic effects [66, 67]. Interestingly, the Nemmar et al.
(2003) found that inflammation and thrombosis were asso-
ciated events at 18 h, but not at 4 h [68]. Particle transloca-
tion could play a role in the early pro-thrombotic effects of
DEP, with inflammation playing a greater role at later
stages. Indirect evidence for this concept is provided by the
finding that intravenous administration of DEP to the blood
has the capacity to increase in vivo thrombosis formation at
2 h, without inducing inflammation [69]. The link between
inflammation and thrombosis at later time points after
pulmonary instillation is possible (6–24 h), but complex
[69]. Smyth et al. (2017) showed intratracheally instillation
of DEP (25 μg) in mice to induce platelet aggregation inde-
pendent of lung inflammation [70]. The study also showed
that platelet aggregation persisted in endothelial nitric oxide
synthase (eNOS) knockout mice [70], suggesting a lesser
influence of vascular-derived mediators in actions of DEP
on platelets. There is some discrepancy regarding the role
of platelets in mediating the pro-thrombotic effects of par-
ticulate air pollution [13, 51, 52, 60–62, 69, 70]. This is
likely due to differences in study designs, including species,
particle types, doses, exposure methods and different meas-
urable indicators of platelet function. An especially note-
worthy study is that by Emmerects et al. (2012) suggesting
that continuous exposure of mice to traffic-related air pol-
lution, in a real-life setting (mice were placed in a highway
tunnel for 25 or 26 days; mean 24.9 μg/m3 PM2.5) may
affect platelet function with an increased release of platelet
derived pro-coagulant microvesicles [13]. This study also
looked at how age modifies the pollution-induced changes
in platelet counts and activation but no clear patterns
emerged [13]. More studies assessing the potential effect
modification by age, as well effects of co-morbidities are
clearly needed. One study has examined hypertension and
demonstrated enhanced platelet aggregation and thrombin
generation 24 h after intratracheal instillation of DEP
(15 μg) in mice induced with experimental hypertension
compared with wildtype controls [71]. There is limited
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evidence to support the assertion that exposure to air pollu-
tion may have a priming effect that leads to an augmented
response to subsequent stimuli [72]. Platelets from CAPs-
exposed mice (PM2.5; 88.5 μg/m
3; 6 h/day; 5 days/week for
2 weeks) showed a 54% increase in fibrinogen binding in
response to the agonist adenosine diphosphate (ADP),
compared to saline exposed mice [72].
As discussed above, impairment of endogenous fibrin-
olysis has been suggested from studies exposing humans
to DE by inhalation under controlled experimental condi-
tions [47, 49]. Subsequent studies showed that this effect
was directly attributable to the exhaust particles [73]. In-
creased aorta PAI-1mRNA levels, suggesting the presence
of vascular injury and/or fibrinolytic activation were ob-
served in rats exposed to O3 (0.38 ppm) or DEP (2.2 mg/
m3) alone for 16 weeks (5 h/day, 1 day/week) [73]. Inter-
estingly, aortic thrombodulin (TM) and t-PA mRNA levels
also increased, which are opposite to the expected direc-
tion of change [73]. Further studies are needed to deter-
mine whether these exposures would reflect similar
changes in corresponding protein levels or activity. A
great advantage of the study design employed by Koda-
vanti et al. (2011) was that they analysed disparities in ex-
posure to both acute (2 days) and sub-chronic (16 weeks)
pollution in the same study. The analysis found that the
associations between exposure and mRNA markers of
haemostasis to be strongest after a longer series of expo-
sures [73]. This study also showed a synergistic decrease
in effects following DE and O3 (0.5 ppm + 2 mg/m
3 5 h/
day; 1 day/week for 16 weeks) co-exposure [73]. Concen-
trations of PAI-1 mRNA in mouse fat tissue has also been
shown to increase following inhalation exposure (8 h per
day, for 3 days) to fine CAPs (PM2.5; 88.5 ± 13.4 μg/m
3)
and after the instillation PM2.5 (200 μg) [61]. Notably,
studies in IL-6 null mice revealed no significant effect of
the loss of IL-6 on the induction of PAI-1 expressions fol-
lowing exposure [61]. Treating wildtype mice with the
TNF-α receptor antagonist etanercept (10 mg/kg i.p.) pre-
vented upregulation of PAI-1 expression following expos-
ure [61]. In contrast etanercept had no effect on PM-
induced thrombus formation [61]. Another study showed
curcumin (45 mg/kg), a compound with anti-
inflammatory and anti-oxidant properties, to block the
DEP-induced up-regulation of TNF-α and PAI-1 in mice
(15 μg DEP via intratracheal instillation, 4 times/week, for
1 week), but to only partially inhibit PM-induced throm-
bosis [66]. Collectively, these data suggests that PM expos-
ure is associated with both the activation of coagulation
and impairment of fibrinolysis, but that these facets are
regulated via distinct mechanisms.
Lastly, this review found limited evidence linking oxi-
dative stress to the effects of pollution exposure on
thrombosis and fibrinolysis. For example, the pulmonary
and systematic inflammation induced by ultrafine carbon
particles (180 μg/m3, 24 h) in aged spontaneously hyper-
tensive rats (SHRs) was associated with increased
hemeoxygenase-1 levels (HO-1; a marker of oxidative
stress), alongside changes in biomarkers of thrombosis
[74]. Additionally, oxidation of the low density lipopro-
tein (LDL) receptor has an influence on the thrombotic
effects of inhaled vehicular emissions [73].
In summary, the majority of animal studies support
the notion that particulate air pollution exposure leads
to an enhanced thrombogenicity. The use of in vivo of
thrombus formation in blood vessels in situ is a strength
of animal studies given that clot formation will be heav-
ily influenced by the vascular wall and flow conditions of
the blood prior to clot formation. Whilst in vivo studies
generally use high air pollution exposures, the similarity
of many of the mechanistic pathways with those shown
in epidemiological and controlled exposure studies in
man suggests that these exposures are relevant. Multiple
mechanisms have been postulated, including inflammation,
oxidative stress, interplay between TF and IL-6 (potentially
independently of other inflammation pathways), increases
in coagulation factors, and impaired fibrinolysis. A role of
platelet activation in the enhanced thrombosis is one of
the most consistent observations. The thrombotic effects
of gaseous pollutants and the use of models of suscep-
tible populations is an avenue for future research, and
one that would provide a useful foundation addressing
these matters in human studies, particularly if dose and
time responses can be defined.
Summary and conclusions
In 2015, ambient air pollution was estimated to be the 5th
leading risk factor for death globally, with CVD account-
ing for the majority of these deaths [2]. Given the global
commitment to reduce premature non-communicable
diseases by 25% by 2025 [75], an improved understanding
of the mechanisms underlying the significant detrimental
effects of air pollution on CVD will help achieve this tar-
get. Specifically, improved knowledge of the mechanistic
pathways linking air pollution to negative effects on car-
diovascular health has the potential to improve policy, and
ultimately improve health and life expectancy of people by
allowing target intervention. In 2010, a seminar review of
literature suggested a role of the haemostatic system to
the overall cardiovascular effects of air pollution, although
a great deal of uncertainty remained [4]. This review dis-
cusses the growing body of evidence from 2009 to 2016,
expanding the remit to include gaseous co-pollutants as
well as airborne particulates of different size fractions.
A large body of work (2326 references screened, 74
assessed) has been published on the topic in the last
seven years. Overall, examination of this literature sup-
ports the contention that exposure to air pollution pro-
motes coagulation and impairs fibrinolysis, leading to an
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unfavourable imbalance in haemostatic factors that
would be expected to increase the risk of thrombotic
events in susceptible individuals. As noted in the AHA
review, inconsistent findings between studies are com-
monplace. However, the volume of publications support-
ing the pro-thrombotic effect of air pollution far
outweigh those showing no effect or the opposite effect,
even given the assumption that there may be a publica-
tion bias towards studies suggesting a health risk of pol-
lutions. Potential reasons for the inconsistencies are
many. In general, the investigations assessed were, in
our opinion, of high scientific quality – both in their de-
sign, implementation and analysis. Instead, a major
source of discrepancies most likely reflects the differ-
ences in study design and increasing complexity of the
endpoints open for investigation. Additionally, the na-
ture of exposure is also likely to play a significant role in
the differences between studies, in a manner that will
depend on the study type under investigation. For ex-
ample, distinguishing the effects of individual pollutants
remains a challenge for epidemiological studies, espe-
cially where there is high correlation between pollutants
(e.g. PM2.5 and NO2 from traffic-derived sources). Con-
trolled exposure studies in man and animals are fre-
quently criticised for the high concentrations of their
exposures; a criticism that still applies to many of the
studies performed in recent years. Indeed, little consen-
sus has been reached in striking a balance between
using a realistic dose that models long-term exposure
with obtaining suitably high exposure to explore
pathogenic mechanisms in short-term studies. How-
ever, the number of studies, both epidemiological and
experimental, assessing the effects of longer periods
of exposure are increasing. Overall, results of these
studies are somewhat reassuring in that the direction
of effect matches those of short-term studies.
Fig. 5 Summary of the main and emerging mechanisms described in the review
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While the remit of this literature review was to address
whether gaseous co-pollutants have haemostatic effects,
there have been too few studies to make this assumption
with any certainty. Epidemiological studies suggest that it
is likely that ambient levels of gases such as NOx, O3, and
possibly SO2, are associated with biomarkers of throm-
botic pathways, however, a paucity of experimental studies
means it is not possible to draw any conclusions as to the
wider functional consequences of such observations, or
address more taxing issues such as causality. Of those few
studies available, it does appear that gases can alter throm-
botic pathways, however, initial indications suggest that
inconsistences between studies could be even greater than
that of PM; an observation that might not be especially
surprising given that our focus is on a physiological
system (the blood) some distance from the initial
organ of exposure (the lung). Obtaining evidence of a
dose-dependency of the effects of gases will again be
important for advancing this area.
While our understanding of the pathophysiologic
mechanisms by which air pollution promotes thrombosis
remains incomplete, significant progress has been made.
Similarities in the pattern of biological actions on the
haemostatic system suggest that the findings of short-
terms studies provide relevant, and valuable, information.
Multiple mechanistic pathways are plausible, including
platelet activation, oxidative stress, interactions between
inflammatory mediators and impaired fibrinolysis. Emer-
ging pathways of interest include the role of circulating
microvesicles, epigenetic modifications and alterations in
sensitivity to the above caused by genetic polymorphisms.
A schematic overview of these pathways is shown in Fig. 5.
There is great complexity in the coagulation cascade and
its interaction with other pathways leading to thrombosis
(see Figs. 2 and 3), with many levels of feedback regulation
(positive and negative). Subsequently, it has been difficult
to disentangle which points in the pathway are pivotal in
driving the haemostatic effects of PM. Increases in circu-
lating fibrinogen are one of the more consistent observa-
tions across studies, thus the availability or activation of
this mediator could be significant. In the same respect,
platelets (and platelet-derived mediators) appear to play
an important role in driving the pro-thrombotic effects of
air pollution. It is likely that these mechanisms act in
concert, and potentially acting synergistically to amplify
the overall effect on the blood. The mechanism by
which inhaled pollutants cause thrombotic effects in
distance vascular beds has not been elucidated further
to any great degree in the publications reviewed here
(refer to [19, 20, 76, 77] for this), although inflammatory
and oxidative mediators remain a possibility, and building
evidence for the translocation of nano-sized particles into
the circulation offer the potential that these particles
could directly interfere with blood factors. Experimental
studies using interventions (e.g. pharmacological inhib-
ition, genetic modifications) to inhibit specific pathways
will be useful in dissecting out the key pathways of inter-
est. Ultimately reducing the health effects of air pollution
will rely on removal of pollutants and a better understand-
ing of these mechanisms will help ascertain which pollut-
ants are most harmful and which populations are most at
risk. Additionally, while primary prevention is the main
desire in this field, there could be value in identifying
medications to prevent specific thrombotic pathways for
those individuals who may be especially susceptible (e.g.
patients with a prior history of ischaemic stroke or CAD)
that have an unavoidable exposure to raised levels of air
pollution (e.g. reside close to traffic).
In summary, the recent evidence supports a role for a
pro-thrombotic effect of air pollution, through the activa-
tion of multiple pathophysiological processes. It is highly
likely that these effects will contribute to the overall cardio-
vascular morbidity associated with air pollution and in-
crease the risk of thrombotic effects in those with pre-
existing CVD. A clearer understanding of dose-dependency
of effects and of the effects of longer-term exposures, would
greatly add to the case for causality of the associations be-
tween long-term average ambient concentrations of air pol-
lutants and indices of cardiovascular morbidity. Key area of
future research will be to assess the role of gaseous pollut-
ants and studies that directly compare potentially suscep-
tible individuals/models with healthy counterparts.
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